Genetic ‘signature’ points to poor blood cancer outcome
Testing for a DNA signature could predict which patients with myeloma – a cancer of immune cells in the blood and bone marrow – are likely to develop more serious disease, with a reduced chance of survival. A team at The Institute of Cancer Research, London, found that cancer cells with the signature gain more […]
